WRF Capital
WRF Capital supports groundbreaking research and early-stage companies that focus on life sciences and enabling technologies.
Business Model: B2B
Revenue: $30.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed WRF Capital Information
Geographic Data
Address: 2815 Eastlake Ave E
City: Seattle
State: WA
Zip: 98102
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
WRF Capital supports groundbreaking research and early-stage companies that focus on life sciences and enabling technologies. WRF Capital is composed of the Washington Research Foundation and WRF Capital. It is a venture investment arm of the Washington Research Foundation. It works with entrepreneurs, research institutions, other investors, and industry partners to transform great ideas into successful Washington-based businesses. It was founded in 1981 and is based in Seattle, Washington.
Contact Phone:
+12063365600
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2014 | FlexMinder | Series A | 1.2M |
| 5/2006 | Uptake Medical | Series A | 9M |
| 6/2020 | WiBotic | Series A | 0 |
| 4/2021 | 2Morrow | Venture Round | 0 |
| 9/2015 | AnswerDash | Seed Round | 0 |
| 9/2020 | ThruWave | Seed Round | 0 |
| 9/2007 | GlobeImmune | Series C | 41.2M |
| 5/2009 | Modumetal | Venture Round | 3.5M |
| 3/2021 | Outpace Bio | Series A | 30M |
| 7/2021 | AdaptX | Series A | 0 |
| 1/2014 | SNUPI Technologies | Series A | 7.5M |
| 3/2001 | Lumera Corporation | Venture Round | 0 |
| 2/2007 | Omeros | Series E | 0 |
| 6/2006 | VLST Corporation | Series B | 55M |
| 3/2020 | Membrion | Series A | 0 |
| 12/2001 | Amnis | Venture Round | 8.8M |
| 2/2022 | Wavely Diagnostics | Seed | 2.2M |
| 1/2007 | Farecast | Series C | 12.1M |
| 8/2022 | Somalytics | Seed Round | 1.9M |
| 2/2015 | STASYS | Series A | 160k |
| 1/2006 | Accium BioSciences | Seed Round | 3M |
| 7/2011 | Mirador Biomedical | Series B | 1.5M |
| 1/2022 | Birch.ai | Seed Round | 0 |
| 1/2020 | Absci | Series D | 0 |
| 6/2013 | Mobisante | Series A | 4.2M |
| 3/2009 | Pathway Medical Technologies | Series D | 42.5M |
| 7/2006 | Alder Biopharmaceuticals | Series B | 16M |
| 2/2022 | Wavely Diagnostics | Seed Round | 0 |
| 1/2022 | Birch.ai | Seed Round | 0 |
| 7/2021 | AdaptX | Series A | 0 |
| 4/2021 | 2Morrow | Venture Round | 0 |
| 3/2021 | Outpace Bio | Series A | 0 |
| 9/2020 | ThruWave | Seed Round | 0 |
| 6/2020 | WiBotic | Series A | 0 |
| 3/2020 | Membrion | Series A | 0 |
| 1/2020 | Absci | Series D | 0 |
| 9/2015 | AnswerDash | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
